File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China

TitleLiver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China
Authors
Ho, KarinChan, Albert
KeywordsConversion therapy
Downstaging
Living donor liver transplantation
Transplant oncology
Issue Date1-Feb-2025
PublisherElsevier
Citation
Hepatobiliary and Pancreatic Diseases International, 2025, v. 24, n. 1, p. 45-49 How to Cite?
DOI: http://dx.doi.org/10.1016/j.hbpd.2024.09.005
AbstractWith the advances in transplant oncology in recent years, the role of liver transplantation has expanded to make curative treatment a possibility for a wider patient population. We highlight strategies in Hong Kong, China that have enabled preoperative prognostication for judicious patient selection, downstaging therapy to definitive treatment, and postoperative therapies that have provided a growing role for liver transplantation in patients with more advanced hepatocellular carcinoma.
Persistent Identifierhttp://hdl.handle.net/10722/357503
ISSN
1499-3872
2023 Impact Factor: 3.6
2023 SCImago Journal Rankings: 0.720
ISI Accession Number ID
WOS:001426337700001

 

DC FieldValueLanguage
dc.contributor.authorHo, Karin-
dc.contributor.authorChan, Albert-
dc.date.accessioned2025-07-22T03:13:08Z-
dc.date.available2025-07-22T03:13:08Z-
dc.date.issued2025-02-01-
dc.identifier.citationHepatobiliary and Pancreatic Diseases International, 2025, v. 24, n. 1, p. 45-49-
dc.identifier.issn1499-3872-
dc.identifier.urihttp://hdl.handle.net/10722/357503-
dc.description.abstractWith the advances in transplant oncology in recent years, the role of liver transplantation has expanded to make curative treatment a possibility for a wider patient population. We highlight strategies in Hong Kong, China that have enabled preoperative prognostication for judicious patient selection, downstaging therapy to definitive treatment, and postoperative therapies that have provided a growing role for liver transplantation in patients with more advanced hepatocellular carcinoma.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofHepatobiliary and Pancreatic Diseases International-
dc.subjectConversion therapy-
dc.subjectDownstaging-
dc.subjectLiving donor liver transplantation-
dc.subjectTransplant oncology-
dc.titleLiver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China-
dc.typeArticle-
dc.identifier.doi10.1016/j.hbpd.2024.09.005-
dc.identifier.scopuseid_2-s2.0-85204495132-
dc.identifier.volume24-
dc.identifier.issue1-
dc.identifier.spage45-
dc.identifier.epage49-
dc.identifier.eissn2352-9377-
dc.identifier.isiWOS:001426337700001-
dc.identifier.issnl2352-9377-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats